The Evolving Global Landscape in Vaccine Development: Novotech and Endpoints News Webinar
The Evolving Global Landscape in Vaccine Development: Novotech and Endpoints News Webinar

SYDNEY, AU, Feb 15, 2023 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific centred biotech CRO with extensive experience in vaccine trials, is convening an expert panel webinar covering the evolving landscape in vaccine development. Register here https://webinars.endpts.com/keeping-pace-with-the-evolving-global-landscape-in-vaccine-development/ Between 2017 and 2021, there were close to 1,400 industry-sponsored single country vaccine based... » read more

InaVac gets emergency approval from BPOM
InaVac gets emergency approval from BPOM

Surabaya, East Java, Indonesia, Nov 14, 2022 – (ACN Newswire via SEAPRWire.com) – The Food and Drug Supervisory Agency (BPOM) has issued emergency use authorization (EUA) for InaVac, a COVID-19 vaccine developed by researchers from Airlangga University (Unair). InaVac, COVID-19 vaccine, is developed by the University of Airlangga in Surabaya, East Java Province. (ANTARA/HO-BPBRIN Unair)... » read more

AIM Vaccine Announces Global Offering Results, Offer Price of HK$16.16 per H Share

HONG KONG, Oct 5, 2022 – (ACN Newswire via SEAPRWire.com) – AIM Vaccine Co., Ltd. (“AIM Vaccine” or the “Company”, together with its subsidiaries, the “Group”, stock code: 06660.HK), the second largest vaccine company in China in terms of 2021 approved lot release volume (excluding COVID-19 vaccines), today announced the allotment results of its Global... » read more

AIM Vaccine Announces Proposed Listing on the Main Board of SEHK
AIM Vaccine Announces Proposed Listing on the Main Board of SEHK

HONG KONG, Sep 23, 2022 – (ACN Newswire via SEAPRWire.com) – AIM Vaccine Co., Ltd. (“AIM Vaccine” or the “Company”, together with its subsidiaries, the “Group”, stock code: 06660.HK), the second largest vaccine company in China in terms of 2021 approved lot release volume (excluding COVID-19 vaccines), announced the proposed listing of its H shares... » read more

Indonesia’s Bio Farma ready to produce ‘IndoVac’ Covid-19 vaccines
Indonesia’s Bio Farma ready to produce ‘IndoVac’ Covid-19 vaccines

BANDUNG, INDONESIA, Sep 12, 2022 – (ACN Newswire via SEAPRWire.com) – PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in manufacturing IndoVac, its Covid-19 vaccines brand, including primary series vaccines, booster vaccines and vaccines for children, in development since November 2021. IndoVac Covid-19 vaccine in production at... » read more

Indonesian pharmaceutical Bio Farma ready to produce IndoVac Covid-19 vaccines
Indonesian pharmaceutical Bio Farma ready to produce IndoVac Covid-19 vaccines

Bandung, W Java, Indonesia, Sep 9, 2022 – (ACN Newswire via SEAPRWire.com) – PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in the manufacturing of IndoVac, a Covid-19 vaccine brand it has developed since November 2021. IndoVac Covid-19 vaccine in production at PT Bio Farma’s facilities near... » read more

Therapeutic Goods Administration Grants Provisional Approval for Moderna’s COVID-19 Vaccine in Children Aged Six Months to Five Years
Therapeutic Goods Administration Grants Provisional Approval for Moderna’s COVID-19 Vaccine in Children Aged Six Months to Five Years

Cambridge, MA, Jul 19, 2022 – (ACN Newswire via SEAPRWire.com) – Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Therapeutic Goods Administration (TGA) in Australia has granted provisional registration for the use of Moderna’s mRNA COVID-19 vaccine, Spikevax, in a two-dose series of 25 ug per... » read more

Novotech Client SK bioscience Achieves SKYCovione(TM) COVID-19 Vaccine Approval in Korea
Novotech Client SK bioscience Achieves SKYCovione(TM) COVID-19 Vaccine Approval in Korea

SEOUL, S.KOREA, Jul 13, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, congratulates its client SK bioscience on the recent COVID-19 vaccine licence approval. SK bioscience and GSK recently announced the successful authorization: SK bioscience announced that ‘SKYCovione(TM),’ South... » read more

Legend Capital’s Portfolio Company Recbio Lists on HKEX Successfully
Legend Capital’s Portfolio Company Recbio Lists on HKEX Successfully

HONG KONG, Apr 7, 2022 – (ACN Newswire via SEAPRWire.com) – On 31 March 2022, Legend Capital’s portfolio company Jiangsu Recbio Technology Co., Ltd. (“Recbio”, stock code: 2179.HK), a leading novel vaccines company, went public on the Hong Kong Stock Exchange. The listing makes Recbio “the first HPV vaccine stock in Hong Kong” and “the... » read more

Therapeutic Goods Administration of Australia Authorizes Moderna’s Covid-19 Vaccine in Children (6-11 Years)
Therapeutic Goods Administration of Australia Authorizes Moderna’s Covid-19 Vaccine in Children (6-11 Years)

Cambridge, MA, Feb 17, 2022 – (ACN Newswire via SEAPRWire.com) – Moderna, Inc., (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Therapeutic Goods Administration (TGA) in Australia has granted provisional registration for the use of Moderna’s mRNA COVID-19 vaccine, Spikevax, in a 50 ug dose, two-dose series, for... » read more